HUP0103064A3 - Polymorphic form of 5-chloro-4-(3-{[2-(3,4-dimethoxy-phenyl)-ethyl]-methyl-amino]-propylamino)-3-(2h)-piridazinone fumarate, its use, process for its preparation and pharmaceutical compositions containing it - Google Patents

Polymorphic form of 5-chloro-4-(3-{[2-(3,4-dimethoxy-phenyl)-ethyl]-methyl-amino]-propylamino)-3-(2h)-piridazinone fumarate, its use, process for its preparation and pharmaceutical compositions containing it

Info

Publication number
HUP0103064A3
HUP0103064A3 HU0103064A HUP0103064A HUP0103064A3 HU P0103064 A3 HUP0103064 A3 HU P0103064A3 HU 0103064 A HU0103064 A HU 0103064A HU P0103064 A HUP0103064 A HU P0103064A HU P0103064 A3 HUP0103064 A3 HU P0103064A3
Authority
HU
Hungary
Prior art keywords
piridazinone
propylamino
fumarate
dimethoxy
chloro
Prior art date
Application number
HU0103064A
Other languages
English (en)
Original Assignee
Egis Gyogyszergyar Nyilvanosan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egis Gyogyszergyar Nyilvanosan filed Critical Egis Gyogyszergyar Nyilvanosan
Priority to HU0103064A priority Critical patent/HUP0103064A3/hu
Publication of HU0103064D0 publication Critical patent/HU0103064D0/hu
Priority to EP02755384A priority patent/EP1417179A1/en
Priority to PL02365483A priority patent/PL365483A1/xx
Priority to YU7604A priority patent/YU7604A/sh
Priority to EA200400222A priority patent/EA200400222A1/ru
Priority to CZ2004124A priority patent/CZ2004124A3/cs
Priority to PCT/HU2002/000076 priority patent/WO2003010150A1/en
Priority to US10/484,621 priority patent/US20040266772A1/en
Priority to IL15996702A priority patent/IL159967A0/xx
Priority to CNA028162587A priority patent/CN1545505A/zh
Priority to JP2003515509A priority patent/JP2004536868A/ja
Priority to CA002454774A priority patent/CA2454774A1/en
Priority to KR10-2004-7001150A priority patent/KR20040030861A/ko
Priority to SK54-2004A priority patent/SK542004A3/sk
Publication of HUP0103064A2 publication Critical patent/HUP0103064A2/hu
Priority to ZA200400483A priority patent/ZA200400483B/en
Publication of HUP0103064A3 publication Critical patent/HUP0103064A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22—Nitrogen and oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Treating Waste Gases (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Silver Salt Photography Or Processing Solution Therefor (AREA)
HU0103064A 2001-07-26 2001-07-26 Polymorphic form of 5-chloro-4-(3-{[2-(3,4-dimethoxy-phenyl)-ethyl]-methyl-amino]-propylamino)-3-(2h)-piridazinone fumarate, its use, process for its preparation and pharmaceutical compositions containing it HUP0103064A3 (en)

Priority Applications (15)

Application Number Priority Date Filing Date Title
HU0103064A HUP0103064A3 (en) 2001-07-26 2001-07-26 Polymorphic form of 5-chloro-4-(3-{[2-(3,4-dimethoxy-phenyl)-ethyl]-methyl-amino]-propylamino)-3-(2h)-piridazinone fumarate, its use, process for its preparation and pharmaceutical compositions containing it
SK54-2004A SK542004A3 (en) 2001-07-26 2002-07-26 Polymorph salt of a pyridazinone derivative for the treatment arrhythmia
PCT/HU2002/000076 WO2003010150A1 (en) 2001-07-26 2002-07-26 Polymorph salt of a pyridazinone derivative for the treatment of arrythmia
IL15996702A IL159967A0 (en) 2001-07-26 2002-07-26 Polymorph salt of a pyridazinone derivative for the treatment of arrythmia
YU7604A YU7604A (sh) 2001-07-26 2002-07-26 Polimorf soli derivata piridazinona za tretman aritmije
EA200400222A EA200400222A1 (ru) 2001-07-26 2002-07-26 Полиморфная соль производного пиридазинона для лечения аритмии
CZ2004124A CZ2004124A3 (cs) 2001-07-26 2002-07-26 Název neuveden
EP02755384A EP1417179A1 (en) 2001-07-26 2002-07-26 Polymorph salt of a pyridazinone derivative for the treatment of arrhythmia
US10/484,621 US20040266772A1 (en) 2001-07-26 2002-07-26 Polymorph salt of a pryridazinone derivative for the treatment of arrythmia
PL02365483A PL365483A1 (en) 2001-07-26 2002-07-26 Polymorph salt of a pyridazinone derivative for the treatment of arrythmia
CNA028162587A CN1545505A (zh) 2001-07-26 2002-07-26 用于治疗心律失常的哒嗪酮衍生物的多晶型盐
JP2003515509A JP2004536868A (ja) 2001-07-26 2002-07-26 不整脈治療用のピリダジノン誘導体の多形体塩
CA002454774A CA2454774A1 (en) 2001-07-26 2002-07-26 Polymorph salt of a pyridazinone derivative for the treatment of arrythmia
KR10-2004-7001150A KR20040030861A (ko) 2001-07-26 2002-07-26 부정맥 치료용의 피리다지논 유도체의 다형 염
ZA200400483A ZA200400483B (en) 2001-07-26 2004-01-22 Polymorph salt of a pyridazinone derivative for the treatment of arrythmia.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0103064A HUP0103064A3 (en) 2001-07-26 2001-07-26 Polymorphic form of 5-chloro-4-(3-{[2-(3,4-dimethoxy-phenyl)-ethyl]-methyl-amino]-propylamino)-3-(2h)-piridazinone fumarate, its use, process for its preparation and pharmaceutical compositions containing it

Publications (3)

Publication Number Publication Date
HU0103064D0 HU0103064D0 (en) 2001-10-28
HUP0103064A2 HUP0103064A2 (hu) 2003-02-28
HUP0103064A3 true HUP0103064A3 (en) 2005-06-28

Family

ID=89979563

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0103064A HUP0103064A3 (en) 2001-07-26 2001-07-26 Polymorphic form of 5-chloro-4-(3-{[2-(3,4-dimethoxy-phenyl)-ethyl]-methyl-amino]-propylamino)-3-(2h)-piridazinone fumarate, its use, process for its preparation and pharmaceutical compositions containing it

Country Status (15)

Country Link
US (1) US20040266772A1 (hu)
EP (1) EP1417179A1 (hu)
JP (1) JP2004536868A (hu)
KR (1) KR20040030861A (hu)
CN (1) CN1545505A (hu)
CA (1) CA2454774A1 (hu)
CZ (1) CZ2004124A3 (hu)
EA (1) EA200400222A1 (hu)
HU (1) HUP0103064A3 (hu)
IL (1) IL159967A0 (hu)
PL (1) PL365483A1 (hu)
SK (1) SK542004A3 (hu)
WO (1) WO2003010150A1 (hu)
YU (1) YU7604A (hu)
ZA (1) ZA200400483B (hu)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU227181B1 (en) * 2002-09-11 2010-09-28 Egis Gyogyszergyar Nyilvanosan Use of 5-chloro-4-[3-[n-[2-(3,4-dimethoxyphenyl)ethyl)]-n-methylamino]-propylamino]-3-(2h)-pyridazinone for producing pharmaceutical compositions having metabolic modulator effect
HU227115B1 (en) * 2003-10-10 2010-07-28 Egis Gyogyszergyar Nyilvanosan Pellets containing pyridazinone derivative
GB201105537D0 (en) * 2011-03-31 2011-05-18 Vantia Ltd New process

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU214320B (hu) * 1991-12-20 1998-03-02 EGIS Gyógyszergyár Rt. Eljárás új 3(2H)-piridazinon-származékok és ezeket tartalmazó gyógyszerkészítmények előállítására
BR9815967A (pt) * 1998-06-05 2004-06-22 Egyt Gyogyszervegyeszeti Gyar Processo para a preparação de um derivado de amino-5-cloro de 3(2h)-piridazinona-4-substituìdo

Also Published As

Publication number Publication date
JP2004536868A (ja) 2004-12-09
CA2454774A1 (en) 2003-02-06
PL365483A1 (en) 2005-01-10
CN1545505A (zh) 2004-11-10
EA200400222A1 (ru) 2004-12-30
SK542004A3 (en) 2004-08-03
YU7604A (sh) 2006-08-17
KR20040030861A (ko) 2004-04-09
CZ2004124A3 (cs) 2004-06-16
ZA200400483B (en) 2005-04-22
EP1417179A1 (en) 2004-05-12
HUP0103064A2 (hu) 2003-02-28
WO2003010150A1 (en) 2003-02-06
HU0103064D0 (en) 2001-10-28
US20040266772A1 (en) 2004-12-30
IL159967A0 (en) 2004-06-20

Similar Documents

Publication Publication Date Title
HUP0400236A3 (en) Polymorphic forms of 1-'4-(5-cyanoindol-3-yl)butyl-4-(2-carbamoylbenzofuran-5-yl)piperazine hydrochloride, process for their preparation and pharmaceutical compositions containing them
HUP0302656A3 (en) Fumaric acid amides, their use for preparation of pharmaceutical compositions and pharmaceutical compositions containing the compounds
IL219397A0 (en) Compounds for the treatment of metabolic disorders, methods of preparing same, and pharmaceutical compositions containing same
HUP0303398A3 (en) 1,2-dihydropyridine compounds, process for preparation of the same and use thereof and pharmaceutical compositions containing the same
HUP0303128A3 (en) Novel succinate salt of o-desmethyl-venlafaxine, process for preparation thereof, its use and pharmaceutical composition containing it
EP1827468A4 (en) LEUPROLID ACETATE AND ACETYLCHOLINESTERASE INHIBITORS OR NMDA RECEPTOR ANTAGONISTS FOR THE TREATMENT OF ALZHEIMER DISEASE
HUP0301463A3 (en) Process for the preparation of substituted octanoyl amides and the intermediates
IL160545A0 (en) (-)-1-(3,4-dichlorophenyl) -3- azabicyclo [3.1.0] hexane, compositions thereof and uses as a dopamine-reuptake inhibitor
HUP0401086A3 (en) 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for preparation of pharmaceutical compositions for the treatment of pain, anxiety or gastrointestinal disorders and process for preparation the compounds
IL159151A0 (en) Stable polymorph of flibanserin, technical process for its preparation and the use thereof for preparing medicaments
HUP0202399A3 (en) Use of dopamine d3 receptor ligands for producing pharmaceutical compositions for treating kidney disorders
HUP0204157A3 (en) 1,3-dihydro-2h-indol-2-one derivatives, process for preparation of the compounds and pharmaceutical compositions containing the same
HUP0104085A3 (en) Use of vasopressin antagonists for the preparation of pharmaceutical compositions treating pulmonary hypertension
HUP0401747A3 (en) Piridazine derivatives of hydrazono-malonitriles, their use, process for preparation of the compounds and pharmaceutical compositions containing the compounds
HK1029339A1 (en) Thermodynamically stable modification of 1-(4-carbazolyloxy)-3-(2-(2-methoxyphenoxy)ethylamino)-2-propanole, process for its preparation and pharmaceutical compositions containing it
HUP0204563A3 (en) Process for preparation of 3,3-diarylpropylamine derivatives and their intermediates and their use for preparation of pharmaceutical compositions
HUP0000960A3 (en) Spray-dried paroxetine hydrochloride, process for it's preparation,use of the compound and pharmaceutical compositions containing the same
IL155041A0 (en) Process for the preparation of n-(substituted phenyl)-3-alkyl-, aryl-and heteroarylsulfonyl-2-hydroxy-2-alkyl-and haloalkylpropanamide compounds
HUP0301862A3 (en) Lactam compound, pharmaceutical composition containing it, process for producing it, intermediates and use of it for producing pharmaceutical composition
GB0112812D0 (en) Mthd for preparation of 10, 11-dihydro-10-hydroxy-5H-dibenz/B,F/azepine-5-c arboxamide and 10,11-dihydro-10-oxo-5H-dibenz/B,F/azepine-5-carb oxamide therefrom
HUP0401325A3 (en) Isoxazolopyridinones useful in the treatment of parkinson's disease, process for their preparation and pharmaceutical compositions containing the compounds
AU2003303141A8 (en) Hydroxypropyl amides for the treatment of alzheimer's disease
SI1170281T1 (sl) Nove spojine 1,1-in 1,2-disubstituirani ciklopropani, postopek za njihovo pripravo in farmacevtski sestavki, ki jih vsebujejo
HUP0103064A3 (en) Polymorphic form of 5-chloro-4-(3-{[2-(3,4-dimethoxy-phenyl)-ethyl]-methyl-amino]-propylamino)-3-(2h)-piridazinone fumarate, its use, process for its preparation and pharmaceutical compositions containing it
BG104243A (en) Method for the synthesis of quinoline derivatives

Legal Events

Date Code Title Description
HC9A Change of name, address

Owner name: EGIS GYOGYSZERGYAR NYILVANOSAN MUEKOEDOE RESZV, HU

Free format text: FORMER OWNER(S): EGIS GYOGYSZERGYAR RT., HU

FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished